Article
CTLA-4 polymorphism contributes to the genetic susceptibility of epithelial ovarian cancer.
The journal of obstetrics and gynaecology research - 1 May 2022
Chen Juan, Kang Shan, Wu Jianlei, Zhao Jian, Si Wengang, Sun Haiyan, Li Yan
Abstract excerpt
AIM: Cytotoxic T-lymphocyte antigen-4 (CTLA-4), an inhibitory molecule on T-cells, plays a key role in tumorigenesis and progression. In the present study, we investigated the effects of three polymorphisms in the CTLA-4 gene on the risk of epithelial ovarian cancer and the clinical outcomes of patients. METHODS: A case-control study was performed in 527 epithelial ovarian cancer patients and 532 controls....
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
